IL131354A0 - Aqueous pharmaceutical composition comprising an active ingredient shich is highly insoluble in water - Google Patents

Aqueous pharmaceutical composition comprising an active ingredient shich is highly insoluble in water

Info

Publication number
IL131354A0
IL131354A0 IL13135498A IL13135498A IL131354A0 IL 131354 A0 IL131354 A0 IL 131354A0 IL 13135498 A IL13135498 A IL 13135498A IL 13135498 A IL13135498 A IL 13135498A IL 131354 A0 IL131354 A0 IL 131354A0
Authority
IL
Israel
Prior art keywords
shich
water
pharmaceutical composition
active ingredient
aqueous pharmaceutical
Prior art date
Application number
IL13135498A
Other languages
English (en)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of IL131354A0 publication Critical patent/IL131354A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13135498A 1997-02-20 1998-02-12 Aqueous pharmaceutical composition comprising an active ingredient shich is highly insoluble in water IL131354A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000363A IT1289939B1 (it) 1997-02-20 1997-02-20 Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
PCT/EP1998/000816 WO1998036735A1 (en) 1997-02-20 1998-02-12 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water

Publications (1)

Publication Number Publication Date
IL131354A0 true IL131354A0 (en) 2001-01-28

Family

ID=11376099

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13135498A IL131354A0 (en) 1997-02-20 1998-02-12 Aqueous pharmaceutical composition comprising an active ingredient shich is highly insoluble in water
IL131354A IL131354A (en) 1997-02-20 1999-08-11 Aphrodisiac preparation containing an active ingredient that is insoluble in water

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL131354A IL131354A (en) 1997-02-20 1999-08-11 Aphrodisiac preparation containing an active ingredient that is insoluble in water

Country Status (26)

Country Link
US (1) US6337087B1 (hu)
EP (1) EP0973505B1 (hu)
JP (1) JP4299369B2 (hu)
KR (1) KR100515249B1 (hu)
CN (1) CN1135969C (hu)
AR (1) AR011682A1 (hu)
AT (1) ATE257374T1 (hu)
AU (1) AU740619B2 (hu)
BG (1) BG64367B1 (hu)
CA (1) CA2285985C (hu)
CZ (1) CZ296700B6 (hu)
DE (1) DE69821001T2 (hu)
DK (1) DK0973505T3 (hu)
EA (1) EA002281B1 (hu)
ES (1) ES2213894T3 (hu)
GE (1) GEP20022751B (hu)
HU (1) HU225594B1 (hu)
IL (2) IL131354A0 (hu)
IT (1) IT1289939B1 (hu)
PL (1) PL190987B1 (hu)
PT (1) PT973505E (hu)
SK (1) SK282905B6 (hu)
TR (1) TR199901987T2 (hu)
UA (1) UA63939C2 (hu)
WO (1) WO1998036735A1 (hu)
ZA (1) ZA981354B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US6075045A (en) * 1999-04-28 2000-06-13 Ajinomoto Co., Inc. Method of treating paralysis of the extremities caused by cerebral infarction
JP4894119B2 (ja) * 2001-09-26 2012-03-14 日油株式会社 脂肪酸含有リポソーム分散液
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
WO2004064736A2 (en) * 2003-01-17 2004-08-05 Threshold Pharmaceuticals, Inc. Treatment of benign prostatic hyperplasia using energolytic agents
US20050238675A1 (en) * 2004-04-26 2005-10-27 Wenjie Li Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US20210290562A1 (en) * 2018-12-11 2021-09-23 Disruption Labs Inc. Compositions for the delivery of therapeutic agents and methods of use and making thereof
CN111759807B (zh) * 2019-04-01 2021-06-01 上海谷森医药有限公司 一种环孢素脂质体及其制备方法
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1264668C (en) * 1984-06-20 1990-01-23 EXTRUSION TECHNIQUES FOR THE PRODUCTION OF LIPOSOMES
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
AT396755B (de) * 1992-07-09 1993-11-25 Oesko Gmbh Verfahren zum reinigen eines rauchgasstromes mit hilfe einer waschflüssigkeit
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
AU6047996A (en) * 1995-06-07 1996-12-30 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications

Also Published As

Publication number Publication date
US6337087B1 (en) 2002-01-08
BG64367B1 (bg) 2004-12-30
BG103739A (en) 2000-06-30
DE69821001T2 (de) 2004-11-11
WO1998036735A1 (en) 1998-08-27
TR199901987T2 (xx) 1999-11-22
CN1135969C (zh) 2004-01-28
HUP0000910A2 (hu) 2000-10-28
KR100515249B1 (ko) 2005-09-16
UA63939C2 (uk) 2004-02-16
AU6398798A (en) 1998-09-09
SK111199A3 (en) 2000-06-12
SK282905B6 (sk) 2003-01-09
ATE257374T1 (de) 2004-01-15
IT1289939B1 (it) 1998-10-19
CA2285985C (en) 2008-01-29
ZA981354B (en) 1998-08-17
CN1255057A (zh) 2000-05-31
JP2001519775A (ja) 2001-10-23
EP0973505A1 (en) 2000-01-26
EA002281B1 (ru) 2002-02-28
EP0973505B1 (en) 2004-01-07
JP4299369B2 (ja) 2009-07-22
CZ292699A3 (cs) 2000-01-12
CA2285985A1 (en) 1998-08-27
PL335208A1 (en) 2000-04-10
KR20000075480A (ko) 2000-12-15
ES2213894T3 (es) 2004-09-01
PL190987B1 (pl) 2006-02-28
PT973505E (pt) 2004-05-31
IL131354A (en) 2010-06-30
DK0973505T3 (da) 2004-05-03
GEP20022751B (en) 2002-08-26
CZ296700B6 (cs) 2006-05-17
HU225594B1 (en) 2007-05-02
DE69821001D1 (de) 2004-02-12
AU740619B2 (en) 2001-11-08
AR011682A1 (es) 2000-08-30
ITMI970363A1 (it) 1998-08-20
EA199900750A1 (ru) 2000-04-24
HUP0000910A3 (en) 2000-11-28

Similar Documents

Publication Publication Date Title
HUP0100970A3 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL131163A (en) Heteroaryl-hexanoic acid amide derivatives, their use in the preparation of medicaments, and pharmaceutical compositions comprising them
HUP0001038A3 (en) Aqueous liquid cleansing and moisturizing composition
IN1998CH01442A (en) Microparticles containing agricultural active ingredients
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
IL127132A0 (en) Substituted imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
ZA982872B (en) Pharmaceutical formulation
DE60003938D1 (de) Wirkstoffe in hydrogel-mikroperlen
HUP9904147A3 (en) Use of water-soluble copolymers as active ingredients in cosmetics
HUP9903216A3 (en) Substituted benzamide and use of them as active ingredient in pharmaceutical compositions
ZA988496B (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
IL131354A0 (en) Aqueous pharmaceutical composition comprising an active ingredient shich is highly insoluble in water
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
EP1047435A4 (en) USE OF AN AQUEOUS SOLUTION IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF LIVE ANIMALS
ZA983239B (en) Stable active human ob protein compositions and methods
HU9802886D0 (en) Substituted heterocyclic benzocycloalkenes and their use as analgetic active ingredients
PL337807A1 (en) Sertralin dosage formulation in the form of a gelatine-encapsulated solution
GB9709739D0 (en) Pharmaceutical formulation